Statin therapy and stroke prevention

被引:39
作者
Vaughan, CJ
Delanty, N
Basson, CT
机构
[1] Cornell Univ, Weill Med Coll, Dept Med, Div Cardiol, New York, NY 10021 USA
[2] Beaumont Hosp, Dept Neurosci, Dublin 9, Ireland
关键词
D O I
10.1097/00001573-200107000-00001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hypercholesterolemia has not traditionally been considered an important risk factor in the pathogenesis of stroke. However, recent studies show that statin therapy significantly reduces ischemic stroke for patients with established coronary artery disease. Statin therapy may reduce stroke through amelioration of precerebral atherosclerosis in the carotid artery and the aorta. Anti-atherosclerotic, anti-inflammatory, and antithrombotic actions of statins occur within the blood and in plaque. Statins may also protect against cerebral ischemia through beneficial modulation of the brain endothelial nitric oxide system. Ongoing studies are exploring the role of statin therapy in the primary prevention of stroke and in the prevention of cognitive decline and multi-infarct cerebrovascular disease. (C) 2001 Lippincott Williams & Wilkins, Inc.
引用
收藏
页码:219 / 224
页数:6
相关论文
共 63 条
[1]   ATHEROSCLEROTIC DISEASE OF THE AORTIC-ARCH AND THE RISK OF ISCHEMIC STROKE [J].
AMARENCO, P ;
COHEN, A ;
TZOURIO, C ;
BERTRAND, B ;
HOMMEL, M ;
BESSON, G ;
CHAUVEL, C ;
TOUBOUL, PJ ;
BOUSSER, MG .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1474-1479
[2]   Platelet-dependent thrombin generation in patients with hyperlipidemia [J].
Aoki, I ;
Aoki, N ;
Kawano, K ;
Shimoyama, K ;
Maki, A ;
Homori, M ;
Yanagisawa, A ;
Yamamoto, M ;
Kawai, Y ;
Ishikawa, K .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 30 (01) :91-96
[3]   CHOLESTEROL REDUCTION AND THE RISK FOR STROKE IN MEN - A METAANALYSIS OF RANDOMIZED, CONTROLLED TRIALS [J].
ATKINS, D ;
PSATY, BM ;
KOEPSELL, TD ;
LONGSTRETH, WT ;
LARSON, EB .
ANNALS OF INTERNAL MEDICINE, 1993, 119 (02) :136-145
[4]   LOVASTATIN INHIBITS LOW-DENSITY-LIPOPROTEIN OXIDATION AND ALTERS ITS FLUIDITY AND UPTAKE BY MACROPHAGES - INVITRO AND INVIVO STUDIES [J].
AVIRAM, M ;
DANKNER, G ;
COGAN, U ;
HOCHGRAF, E ;
BROOK, JG .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1992, 41 (03) :229-235
[5]   PLATELET DEPOSITION AT HIGH SHEAR RATES IS ENHANCED BY HIGH PLASMA-CHOLESTEROL LEVELS - INVIVO STUDY IN THE RABBIT MODEL [J].
BADIMON, JJ ;
BADIMON, L ;
TURITTO, VT ;
FUSTER, V .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (02) :395-402
[6]  
BAIDASSARRE D, 1997, CLIN PHARMACOL THER, V61, P684
[7]   HMG-CoA reductase inhibitors reduce MMP-9 secretion by macrophages [J].
Bellosta, S ;
Via, D ;
Canavesi, M ;
Pfister, P ;
Fumagalli, R ;
Paoletti, R ;
Bernini, F .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1998, 18 (11) :1671-1678
[8]   INTERLEUKIN-1 (IL-1) INDUCES BIOSYNTHESIS AND CELL-SURFACE EXPRESSION OF PROCOAGULANT ACTIVITY IN HUMAN VASCULAR ENDOTHELIAL-CELLS [J].
BEVILACQUA, MP ;
POBER, JS ;
MAJEAU, GR ;
COTRAN, RS ;
GIMBRONE, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1984, 160 (02) :618-623
[9]   Stroke, statins, and cholesterol - A meta-analysis of randomized, placebo-controlled, double-blind trials with HMG-CoA reductase inhibitors [J].
Blauw, GJ ;
Lagaay, AM ;
Smelt, AHM ;
Westendorp, RGJ .
STROKE, 1997, 28 (05) :946-950
[10]   REGRESSION OF CORONARY-ARTERY DISEASE AS A RESULT OF INTENSIVE LIPID-LOWERING THERAPY IN MEN WITH HIGH-LEVELS OF APOLIPOPROTEIN-B [J].
BROWN, G ;
ALBERS, JJ ;
FISHER, LD ;
SCHAEFER, SM ;
LIN, JT ;
KAPLAN, C ;
ZHAO, XQ ;
BISSON, BD ;
FITZPATRICK, VF ;
DODGE, HT .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (19) :1289-1298